Ticagrelor as an alternative in clopidogrel-associated neutropenia.


Aspirin in combination with platelet P2Y12 receptor blocker has become the mainstay antiplatelet treatment strategy for the prevention of stent thrombosis. Ticlopidine was the first widely used P2Y12 receptor blockers, but clopidogrel has mostly replaced the use of ticlopidine due to its more favorable adverse event profile on bone marrow. However, when… (More)
DOI: 10.3109/09537104.2013.867427


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics